Evidence map›Paper›PMID 31714748›Full record

ArticleAnalytical chemistry2019

Perspective on the Future Role of Aptamers in Analytical Chemistry.

Yao Wu, Israel Belmonte, Kiana S Sykes, Yi Xiao, Ryan J White

Abstract read
In one paragraph

Article in Analytical chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Review
  2. InRSC advances · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. MgMikrochimica acta · 2024
    Article
  12. Rationally Designed DNA-Based Scaffolds and Switching Probes for Protein Sensing.Advances in biochemical engineering/biotechnology · 2024
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Aptamer-based Advances in Skin Cancer Research.Current medicinal chemistry · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yao WuDepartment of Chemistry , University of Cincinnati , Cincinnati , Ohio 45221 , United States.ORCID 0000-0003-1296-6569
Israel BelmonteDepartment of Chemistry , University of Cincinnati , Cincinnati , Ohio 45221 , United States.ORCID 0000-0002-8716-7692
Kiana S SykesDepartment of Chemistry , University of Cincinnati , Cincinnati , Ohio 45221 , United States.ORCID 0000-0002-6160-1024
Yi XiaoDepartment of Chemistry and Biochemistry , Florida International University , Miami , Florida 33199 , United States.ORCID 0000-0001-7278-9811
Ryan J WhiteDepartment of Chemistry , University of Cincinnati , Cincinnati , Ohio 45221 , United States.ORCID 0000-0003-0849-0457

Funding

Modular monitoring of hormone release from human isletsUC4DK116283 · NIDDK · FLORIDA STATE UNIVERSITY · PI HUGHES, CHRISTOPHER C. W., ROPER, MICHAEL GABRIEL · 2017 to 2017
$2.0M
Aptamer-Hydrogel Hybrid Sensors for Continuous Therapeutic Drug MonitoringR01GM117159 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE COUNTY · PI WHITE, RYAN J. · 2016 to 2020
$1.2M
NIDDK NIH HHS UC4 DK116283NIGMS NIH HHS R01 GM117159
6 · The paper itself

Abstract

It has been almost 30 years since the invention of Systematic Evolution of Ligands by Exponential Enrichment (SELEX) methodology and the description of the first aptamers. In retrospect over the past 30 years, advances in aptamer development and application have demonstrated that aptamers are potentially useful reagents that can be employed in diverse areas within analytical chemistry, biotechnology, biomedicine, and molecular biology. While often touted as artificial antibodies with an ability to be selected for any target, aptamer development, unfortunately, lags behind development of analytical methodologies that employ aptamers, hindering deeper integration into the application of analytical tool development. This perspective covers recent advances in SELEX methodology for improving efficiency of the SELEX procedure and enhancing affinity and specificity of the selected aptamers, what we view as a critical barrier in the future role of aptamers in analytical chemistry. We discuss postselection modifications that can be used for enhancing performance of the selected aptamers in an analytical device by including understanding intermolecular interaction forces in the binding domain. While highlighting promising properties of aptamers that enable several analytical advances, we provide discussion on the challenges of penetration of aptamers in the analytical field.

Indexed as

Affinity LabelsAptamers, NucleotideLigandsNucleic AcidsSELEX Aptamer TechniqueAffinity LabelsAptamers, NucleotideLigandsNucleic Acids

Identifiers

PMID31714748
PMCPMC10184572

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.